The move should increase Aenova's production of tablets by an estimated 10 billion tablets each year, according to Aenova.
Contract manufacturer Aenova Group (Pähl, Germany) just opened a state-of-the-art production facility in Tittmoning, Germany. The move should increase Aenova's production of tablets by an estimated 10 billion tablets each year, according to Aenova.
Aenova Group is a contract manufacturer of granules, tablets, film-coated tablets, and dragées. The company’s new facility reduces processing times for the manufacturing of high-volume pharmaceuticals and dietary supplements.
An opening ceremony for the Tittmoning facility was scheduled for September 29.
Aenova also offers individual packaging solutions. For more information, visit Aenova's website.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.